Federal action is critical to curb PBMs’ anti-competitive practices and to call for accountability for that market.Though prescription drugs arrives up a loser in the Bush price range, some growing old initiatives are Evidently to the White Property’s radar screen.Companies are gravely anxious that modifications on the Inflation Reduction Act�